Ihre Suche nach:
90 Ergebnis(se) in 0.03 s
-
DUKAS_118629658_EYE
‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
ÔThere is a fear that this will eradicate dwarfismÕ: the controversy over a new growth drug. A new treatment could help children with achondroplasia, the most common form of dwarfism, grow taller and avoid health problems in later life. But there are concerns about whether this is ethical. Pictured is 9 year old Samuel Gray at home in Rugby who is taking part in a Biomarin research drug trial for achondroplasia - vorsitide phase 3.
Sanuel is pictured with pet dog Hamish.
Photo by Fabio De Paola** Clearance required prior to publication**
© Fabio De Paola / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_118629666_EYE
‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
ÔThere is a fear that this will eradicate dwarfismÕ: the controversy over a new growth drug. A new treatment could help children with achondroplasia, the most common form of dwarfism, grow taller and avoid health problems in later life. But there are concerns about whether this is ethical. Pictured is 9 year old Samuel Gray at home in Rugby who is taking part in a Biomarin research drug trial for achondroplasia - vorsitide phase 3.
Photo by Fabio De Paola** Clearance required prior to publication**
© Fabio De Paola / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_118629659_EYE
‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
ÔThere is a fear that this will eradicate dwarfismÕ: the controversy over a new growth drug. A new treatment could help children with achondroplasia, the most common form of dwarfism, grow taller and avoid health problems in later life. But there are concerns about whether this is ethical. Pictured is 9 year old Samuel Gray at home in Rugby who is taking part in a Biomarin research drug trial for achondroplasia - vorsitide phase 3.
Photo by Fabio De Paola** Clearance required prior to publication**
© Fabio De Paola / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_118629679_EYE
‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
ÔThere is a fear that this will eradicate dwarfismÕ: the controversy over a new growth drug. A new treatment could help children with achondroplasia, the most common form of dwarfism, grow taller and avoid health problems in later life. But there are concerns about whether this is ethical. Pictured is 9 year old Samuel Gray at home in Rugby who is taking part in a Biomarin research drug trial for achondroplasia - vorsitide phase 3.
Sanuel is pictured playing on his drum set.
Photo by Fabio De Paola** Clearance required prior to publication**
© Fabio De Paola / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_118629681_EYE
‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
ÔThere is a fear that this will eradicate dwarfismÕ: the controversy over a new growth drug. A new treatment could help children with achondroplasia, the most common form of dwarfism, grow taller and avoid health problems in later life. But there are concerns about whether this is ethical. Pictured is 9 year old Samuel Gray at home in Rugby who is taking part in a Biomarin research drug trial for achondroplasia - vorsitide phase 3.
Sanuel is pictured playing on his drum set.
Photo by Fabio De Paola** Clearance required prior to publication**
© Fabio De Paola / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_118629667_EYE
‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
ÔThere is a fear that this will eradicate dwarfismÕ: the controversy over a new growth drug. A new treatment could help children with achondroplasia, the most common form of dwarfism, grow taller and avoid health problems in later life. But there are concerns about whether this is ethical. Pictured is 9 year old Samuel Gray at home in Rugby who is taking part in a Biomarin research drug trial for achondroplasia - vorsitide phase 3.
Photo by Fabio De Paola** Clearance required prior to publication**
© Fabio De Paola / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_118629668_EYE
‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
ÔThere is a fear that this will eradicate dwarfismÕ: the controversy over a new growth drug. A new treatment could help children with achondroplasia, the most common form of dwarfism, grow taller and avoid health problems in later life. But there are concerns about whether this is ethical. Pictured is 9 year old Samuel Gray at home in Rugby who is taking part in a Biomarin research drug trial for achondroplasia - vorsitide phase 3.
Photo by Fabio De Paola** Clearance required prior to publication**
© Fabio De Paola / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_118629664_EYE
‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
ÔThere is a fear that this will eradicate dwarfismÕ: the controversy over a new growth drug. A new treatment could help children with achondroplasia, the most common form of dwarfism, grow taller and avoid health problems in later life. But there are concerns about whether this is ethical. Pictured is 9 year old Samuel Gray at home in Rugby who is taking part in a Biomarin research drug trial for achondroplasia - vorsitide phase 3.
Photo by Fabio De Paola** Clearance required prior to publication**
© Fabio De Paola / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_118629662_EYE
‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
ÔThere is a fear that this will eradicate dwarfismÕ: the controversy over a new growth drug. A new treatment could help children with achondroplasia, the most common form of dwarfism, grow taller and avoid health problems in later life. But there are concerns about whether this is ethical. Pictured is 9 year old Samuel Gray at home in Rugby who is taking part in a Biomarin research drug trial for achondroplasia - vorsitide phase 3.
Photo by Fabio De Paola** Clearance required prior to publication**
© Fabio De Paola / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_118629665_EYE
‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
ÔThere is a fear that this will eradicate dwarfismÕ: the controversy over a new growth drug. A new treatment could help children with achondroplasia, the most common form of dwarfism, grow taller and avoid health problems in later life. But there are concerns about whether this is ethical. Pictured is 9 year old Samuel Gray at home in Rugby who is taking part in a Biomarin research drug trial for achondroplasia - vorsitide phase 3.
Sanuel is pictured with pet dog Hamish.
Photo by Fabio De Paola** Clearance required prior to publication**
© Fabio De Paola / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_118629672_EYE
‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
ÔThere is a fear that this will eradicate dwarfismÕ: the controversy over a new growth drug. A new treatment could help children with achondroplasia, the most common form of dwarfism, grow taller and avoid health problems in later life. But there are concerns about whether this is ethical. Pictured is 9 year old Samuel Gray at home in Rugby who is taking part in a Biomarin research drug trial for achondroplasia - vorsitide phase 3.
Sanuel is pictured with mum Kristina Gray and pet dog Hamish.
Photo by Fabio De Paola** Clearance required prior to publication**
© Fabio De Paola / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_118629661_EYE
‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
ÔThere is a fear that this will eradicate dwarfismÕ: the controversy over a new growth drug. A new treatment could help children with achondroplasia, the most common form of dwarfism, grow taller and avoid health problems in later life. But there are concerns about whether this is ethical. Pictured is 9 year old Samuel Gray at home in Rugby who is taking part in a Biomarin research drug trial for achondroplasia - vorsitide phase 3.
Photo by Fabio De Paola** Clearance required prior to publication**
© Fabio De Paola / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_118629660_EYE
‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
ÔThere is a fear that this will eradicate dwarfismÕ: the controversy over a new growth drug. A new treatment could help children with achondroplasia, the most common form of dwarfism, grow taller and avoid health problems in later life. But there are concerns about whether this is ethical. Pictured is 9 year old Samuel Gray at home in Rugby who is taking part in a Biomarin research drug trial for achondroplasia - vorsitide phase 3.
Photo by Fabio De Paola** Clearance required prior to publication**
© Fabio De Paola / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_118629663_EYE
‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
ÔThere is a fear that this will eradicate dwarfismÕ: the controversy over a new growth drug. A new treatment could help children with achondroplasia, the most common form of dwarfism, grow taller and avoid health problems in later life. But there are concerns about whether this is ethical. Pictured is 9 year old Samuel Gray at home in Rugby who is taking part in a Biomarin research drug trial for achondroplasia - vorsitide phase 3.
Photo by Fabio De Paola** Clearance required prior to publication**
© Fabio De Paola / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_118629675_EYE
‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
ÔThere is a fear that this will eradicate dwarfismÕ: the controversy over a new growth drug. A new treatment could help children with achondroplasia, the most common form of dwarfism, grow taller and avoid health problems in later life. But there are concerns about whether this is ethical. Pictured is 9 year old Samuel Gray at home in Rugby who is taking part in a Biomarin research drug trial for achondroplasia - vorsitide phase 3.
Sanuel is pictured with pet dog Hamish.
Photo by Fabio De Paola** Clearance required prior to publication**
© Fabio De Paola / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_118629670_EYE
‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
ÔThere is a fear that this will eradicate dwarfismÕ: the controversy over a new growth drug. A new treatment could help children with achondroplasia, the most common form of dwarfism, grow taller and avoid health problems in later life. But there are concerns about whether this is ethical. Pictured is 9 year old Samuel Gray at home in Rugby who is taking part in a Biomarin research drug trial for achondroplasia - vorsitide phase 3.
Sanuel is pictured with pet dog Hamish.
Photo by Fabio De Paola** Clearance required prior to publication**
© Fabio De Paola / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_118629669_EYE
‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
ÔThere is a fear that this will eradicate dwarfismÕ: the controversy over a new growth drug. A new treatment could help children with achondroplasia, the most common form of dwarfism, grow taller and avoid health problems in later life. But there are concerns about whether this is ethical. Pictured is 9 year old Samuel Gray at home in Rugby who is taking part in a Biomarin research drug trial for achondroplasia - vorsitide phase 3.
Photo by Fabio De Paola** Clearance required prior to publication**
© Fabio De Paola / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_118629671_EYE
‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
ÔThere is a fear that this will eradicate dwarfismÕ: the controversy over a new growth drug. A new treatment could help children with achondroplasia, the most common form of dwarfism, grow taller and avoid health problems in later life. But there are concerns about whether this is ethical. Pictured is 9 year old Samuel Gray at home in Rugby who is taking part in a Biomarin research drug trial for achondroplasia - vorsitide phase 3.
Photo by Fabio De Paola** Clearance required prior to publication**
© Fabio De Paola / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_118629677_EYE
‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
ÔThere is a fear that this will eradicate dwarfismÕ: the controversy over a new growth drug. A new treatment could help children with achondroplasia, the most common form of dwarfism, grow taller and avoid health problems in later life. But there are concerns about whether this is ethical. Pictured is 9 year old Samuel Gray at home in Rugby who is taking part in a Biomarin research drug trial for achondroplasia - vorsitide phase 3.
Sanuel is pictured with pet dog Hamish.
Photo by Fabio De Paola** Clearance required prior to publication**
© Fabio De Paola / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_118629678_EYE
‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
ÔThere is a fear that this will eradicate dwarfismÕ: the controversy over a new growth drug. A new treatment could help children with achondroplasia, the most common form of dwarfism, grow taller and avoid health problems in later life. But there are concerns about whether this is ethical. Pictured is 9 year old Samuel Gray at home in Rugby who is taking part in a Biomarin research drug trial for achondroplasia - vorsitide phase 3.
Sanuel is pictured with pet dog Hamish.
Photo by Fabio De Paola** Clearance required prior to publication**
© Fabio De Paola / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_118629680_EYE
‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
ÔThere is a fear that this will eradicate dwarfismÕ: the controversy over a new growth drug. A new treatment could help children with achondroplasia, the most common form of dwarfism, grow taller and avoid health problems in later life. But there are concerns about whether this is ethical. Pictured is 9 year old Samuel Gray at home in Rugby who is taking part in a Biomarin research drug trial for achondroplasia - vorsitide phase 3.
Sanuel is pictured with pet dog Hamish.
Photo by Fabio De Paola** Clearance required prior to publication**
© Fabio De Paola / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_118629676_EYE
‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
ÔThere is a fear that this will eradicate dwarfismÕ: the controversy over a new growth drug. A new treatment could help children with achondroplasia, the most common form of dwarfism, grow taller and avoid health problems in later life. But there are concerns about whether this is ethical. Pictured is 9 year old Samuel Gray at home in Rugby who is taking part in a Biomarin research drug trial for achondroplasia - vorsitide phase 3.
Sanuel is pictured with pet dog Hamish.
Photo by Fabio De Paola** Clearance required prior to publication**
© Fabio De Paola / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_118629674_EYE
‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
ÔThere is a fear that this will eradicate dwarfismÕ: the controversy over a new growth drug. A new treatment could help children with achondroplasia, the most common form of dwarfism, grow taller and avoid health problems in later life. But there are concerns about whether this is ethical. Pictured is 9 year old Samuel Gray at home in Rugby who is taking part in a Biomarin research drug trial for achondroplasia - vorsitide phase 3.
Sanuel is pictured with pet dog Hamish.
Photo by Fabio De Paola** Clearance required prior to publication**
© Fabio De Paola / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_118629673_EYE
‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
ÔThere is a fear that this will eradicate dwarfismÕ: the controversy over a new growth drug. A new treatment could help children with achondroplasia, the most common form of dwarfism, grow taller and avoid health problems in later life. But there are concerns about whether this is ethical. Pictured is 9 year old Samuel Gray at home in Rugby who is taking part in a Biomarin research drug trial for achondroplasia - vorsitide phase 3.
Sanuel is pictured with pet dog Hamish.
Photo by Fabio De Paola** Clearance required prior to publication**
© Fabio De Paola / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUKAS_118629682_EYE
‘There is a fear that this will eradicate dwarfism’: the controversy over a new growth drug
ÔThere is a fear that this will eradicate dwarfismÕ: the controversy over a new growth drug. A new treatment could help children with achondroplasia, the most common form of dwarfism, grow taller and avoid health problems in later life. But there are concerns about whether this is ethical. Pictured is 9 year old Samuel Gray at home in Rugby who is taking part in a Biomarin research drug trial for achondroplasia - vorsitide phase 3.
Sanuel is pictured with pet dog Hamish.
Photo by Fabio De Paola** Clearance required prior to publication**
© Fabio De Paola / Guardian / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Guardian / eyevine. All Rights Reserved. -
DUK10053184_070
FEATURE - Hundeparade: Westminster Dog Show in New York
(2/13/2017) Judging for best in breed categories started at Pier 92 during the Westminster Kennel Club's 141 annual Best In Show dog show. Hundreds of breeds, styles, sizes, colors & temperaments were brought to Manhattan's West Side as owners & handlers put on last minute touches hoping to win North America's most coveted dog show title: Best in Show. (Photo by Andy Katz / Pacific Press) *** Please Use Credit from Credit Field *** *** Local Caption *** 19516917
(c) Dukas -
DUKAS_41971074_POL
Smithsonian breeds endangered species
July 24, 2014 - Front Royal, Virginia, United States: Cheetahs feed at the Cheetah Science Facility at the Smithsonian Conservation Biology Institute. A high priority is maintaining and increasing genetic diversity in small populations to avoid inbreeding, which causes poor fertility and increased disease susceptibility. Scientists work closely with zoos worldwide to develop assisted reproduction techniques, including artificial insemination, in vitro fertilization, embryo transfer and cryopreservation (freezing) of sperm and embryos. (Evelyn Hockstein/Polaris) (FOTO:DUKAS/POLARIS)
DUKAS/POLARIS -
DUKAS_41971073_POL
Smithsonian breeds endangered species
July 24, 2014 - Front Royal, Virginia, United States: Casey Bata puts out a tray of meat to feed the cheetahs at the Cheetah Science Facility at the Smithsonian Conservation Biology Institute. A high priority is maintaining and increasing genetic diversity in small populations to avoid inbreeding, which causes poor fertility and increased disease susceptibility. Scientists work closely with zoos worldwide to develop assisted reproduction techniques, including artificial insemination, in vitro fertilization, embryo transfer and cryopreservation (freezing) of sperm and embryos. (Evelyn Hockstein/Polaris) (FOTO:DUKAS/POLARIS)
DUKAS/POLARIS -
DUKAS_41971072_POL
Smithsonian breeds endangered species
July 24, 2014 - Front Royal, Virginia, United States: Dr. Adrienne Croiser, a cheetah biologist, at the Cheetah Science Facility at the Smithsonian Conservation Biology Institute in Front Royal, Virginia, prepares to deliver food to the cheetahs. A high priority is maintaining and increasing genetic diversity in small populations to avoid inbreeding, which causes poor fertility and increased disease susceptibility. Scientists work closely with zoos worldwide to develop assisted reproduction techniques, including artificial insemination, in vitro fertilization, embryo transfer and cryopreservation (freezing) of sperm and embryos. (Evelyn Hockstein/Polaris) (FOTO:DUKAS/POLARIS)
DUKAS/POLARIS -
DUKAS_41971069_POL
Smithsonian breeds endangered species
July 24, 2014 - Front Royal, Virginia, United States: Dr. Adrienne Croiser, a cheetah biologist, at the Cheetah Science Facility at the Smithsonian Conservation Biology Institute. A high priority is maintaining and increasing genetic diversity in small populations to avoid inbreeding, which causes poor fertility and increased disease susceptibility. Scientists work closely with zoos worldwide to develop assisted reproduction techniques, including artificial insemination, in vitro fertilization, embryo transfer and cryopreservation (freezing) of sperm and embryos. (Evelyn Hockstein/Polaris) (FOTO:DUKAS/POLARIS)
DUKAS/POLARIS -
DUKAS_41971068_POL
Smithsonian breeds endangered species
July 24, 2014 - Front Royal, Virginia, United States: Casey Bata puts out a tray of meat to feed the cheetahs at the Cheetah Science Facility at the Smithsonian Conservation Biology Institute. A high priority is maintaining and increasing genetic diversity in small populations to avoid inbreeding, which causes poor fertility and increased disease susceptibility. Scientists work closely with zoos worldwide to develop assisted reproduction techniques, including artificial insemination, in vitro fertilization, embryo transfer and cryopreservation (freezing) of sperm and embryos. (Evelyn Hockstein/Polaris) (FOTO:DUKAS/POLARIS)
DUKAS/POLARIS -
DUKAS_41971067_POL
Smithsonian breeds endangered species
July 24, 2014 - Front Royal, Virginia, United States: Dr Adrienne Croiser, a cheetah biologist (left) and Casey Bata prepare food for the cheetahs at the Cheetah Science Facility at the Smithsonian Conservation Biology Institute. A high priority is maintaining and increasing genetic diversity in small populations to avoid inbreeding, which causes poor fertility and increased disease susceptibility. Scientists work closely with zoos worldwide to develop assisted reproduction techniques, including artificial insemination, in vitro fertilization, embryo transfer and cryopreservation (freezing) of sperm and embryos. (Evelyn Hockstein/Polaris) (FOTO:DUKAS/POLARIS)
DUKAS/POLARIS -
DUKAS_41971064_POL
Smithsonian breeds endangered species
July 24, 2014 - Front Royal, Virginia, United States: Young cheetahs who were born at the Cheetah Science Facility at the Smithsonian Conservation Biology Institute. A high priority is maintaining and increasing genetic diversity in small populations to avoid inbreeding, which causes poor fertility and increased disease susceptibility. Scientists work closely with zoos worldwide to develop assisted reproduction techniques, including artificial insemination, in vitro fertilization, embryo transfer and cryopreservation (freezing) of sperm and embryos. (Evelyn Hockstein/Polaris) (FOTO:DUKAS/POLARIS)
DUKAS/POLARIS -
DUKAS_41971059_POL
Smithsonian breeds endangered species
July 24, 2014 - Front Royal, Virginia, United States: A young cheetah who was born at the Cheetah Science Facility at the Smithsonian Conservation Biology Institute. A high priority is maintaining and increasing genetic diversity in small populations to avoid inbreeding, which causes poor fertility and increased disease susceptibility. Scientists work closely with zoos worldwide to develop assisted reproduction techniques, including artificial insemination, in vitro fertilization, embryo transfer and cryopreservation (freezing) of sperm and embryos. (Evelyn Hockstein/Polaris) (FOTO:DUKAS/POLARIS)
DUKAS/POLARIS -
DUKAS_41971058_POL
Smithsonian breeds endangered species
July 24, 2014 - Front Royal, Virginia, United States: Cheetah cubs born at the Cheetah Science Facility at the Smithsonian Conservation Biology Institute. A high priority is maintaining and increasing genetic diversity in small populations to avoid inbreeding, which causes poor fertility and increased disease susceptibility. Scientists work closely with zoos worldwide to develop assisted reproduction techniques, including artificial insemination, in vitro fertilization, embryo transfer and cryopreservation (freezing) of sperm and embryos. (Evelyn Hockstein/Polaris) (FOTO:DUKAS/POLARIS)
DUKAS/POLARIS -
DUKAS_41971055_POL
Smithsonian breeds endangered species
July 24, 2014 - Front Royal, Virginia, United States: Casey Bata prepares a tray of meat to feed the cheetahs at the Cheetah Science Facility at the Smithsonian Conservation Biology Institute. A high priority is maintaining and increasing genetic diversity in small populations to avoid inbreeding, which causes poor fertility and increased disease susceptibility. Scientists work closely with zoos worldwide to develop assisted reproduction techniques, including artificial insemination, in vitro fertilization, embryo transfer and cryopreservation (freezing) of sperm and embryos. (Evelyn Hockstein/Polaris) (FOTO:DUKAS/POLARIS)
DUKAS/POLARIS -
DUKAS_41971051_POL
Smithsonian breeds endangered species
July 24, 2014 - Front Royal, Virginia, United States: Cheetah cubs born at the Cheetah Science Facility at the Smithsonian Conservation Biology Institute. A high priority is maintaining and increasing genetic diversity in small populations to avoid inbreeding, which causes poor fertility and increased disease susceptibility. Scientists work closely with zoos worldwide to develop assisted reproduction techniques, including artificial insemination, in vitro fertilization, embryo transfer and cryopreservation (freezing) of sperm and embryos. (Evelyn Hockstein/Polaris) (FOTO:DUKAS/POLARIS)
DUKAS/POLARIS -
DUKAS_41971046_POL
Smithsonian breeds endangered species
July 24, 2014 - Front Royal, Virginia, United States: Research scientist, Budhan Pukazhenthi, outside the Species Survival Cryoperservation and Storage facility, at the Smithsonian Conservation Biology Institute. The National Zoo maintains a valuable living repository of specimens from rare and endangered species in the Genome Resource Bank to support efforts in biodiversity and species conservation.(Evelyn Hockstein/Polaris) (FOTO:DUKAS/POLARIS)
DUKAS/POLARIS -
DUKAS_41971035_POL
Smithsonian breeds endangered species
July 24, 2014 - Front Royal, Virginia, United States: Dr. Adrienne Croiser, a cheetah biologist, with cheetah cubs born at the Cheetah Science Facility at the Smithsonian Conservation Biology Institute. A high priority is maintaining and increasing genetic diversity in small populations to avoid inbreeding, which causes poor fertility and increased disease susceptibility. Scientists work closely with zoos worldwide to develop assisted reproduction techniques, including artificial insemination, in vitro fertilization, embryo transfer and cryopreservation (freezing) of sperm and embryos. (Evelyn Hockstein/Polaris) (FOTO:DUKAS/POLARIS)
DUKAS/POLARIS -
DUKAS_41971033_POL
Smithsonian breeds endangered species
July 24, 2014 - Front Royal, Virginia, United States: Dama gazelles are bred at the Smithsonian Conservation Biology Institute. The World Conservation Union's Red List of Threatened Species lists the dama gazelle as critically endangered. There may be only a few hundred of these gazelles left in the wild. (Evelyn Hockstein/Polaris) (FOTO:DUKAS/POLARIS)
DUKAS/POLARIS -
DUKAS_41971031_POL
Smithsonian breeds endangered species
July 24, 2014 - Front Royal, Virginia, United States: Research scientist, Budhan Pukazhenthi, opens a tank containing frozen animal sperm, at the Smithsonian Conservation Biology Institute. The National Zoo maintains a valuable living repository of specimens from rare and endangered species in the Genome Resource Bank to support efforts in biodiversity and species conservation.(Evelyn Hockstein/Polaris) (FOTO:DUKAS/POLARIS)
DUKAS/POLARIS -
DUKAS_41971028_POL
Smithsonian breeds endangered species
July 24, 2014 - Front Royal, Virginia, United States: Dolores Reed, a supervisory biologist, with Przewalski's horses at the Smithsonian Conservation Biology Institute. The horses were considered extinct in the wild until 2008, when the World Conservation Union reclassified them as critically endangered. Scientists at the Zoo are working to increase the genetic diversity of Przewalski's horses. (Evelyn Hockstein/Polaris) (FOTO:DUKAS/POLARIS)
DUKAS/POLARIS -
DUKAS_41971027_POL
Smithsonian breeds endangered species
July 24, 2014 - Front Royal, Virginia, United States: The feeding schedule for endangered gazelles and horses hangs on the wall of a barn at the Smithsonian Conservation Biology Institute. The World Conservation Union's Red List of Threatened Species lists the dama gazelle as critically endangered. There may be only a few hundred of these gazelles left in the wild. (Evelyn Hockstein/Polaris) (FOTO:DUKAS/POLARIS)
DUKAS/POLARIS -
DUKAS_41971026_POL
Smithsonian breeds endangered species
July 24, 2014 - Front Royal, Virginia, United States: Dama gazelles are bred at the Smithsonian Conservation Biology Institute. The World Conservation Union's Red List of Threatened Species lists the dama gazelle as critically endangered. There may be only a few hundred of these gazelles left in the wild. (Evelyn Hockstein/Polaris) (FOTO:DUKAS/POLARIS)
DUKAS/POLARIS -
DUKAS_41971025_POL
Smithsonian breeds endangered species
July 24, 2014 - Front Royal, Virginia, United States: Dolores Reed, supervisory biologist, gives a treat to dama gazelles at the Smithsonian Conservation Biology Institute. The World Conservation Union's Red List of Threatened Species lists the dama gazelle as critically endangered. There may be only a few hundred of these gazelles left in the wild. (Evelyn Hockstein/Polaris) (FOTO:DUKAS/POLARIS)
DUKAS/POLARIS -
DUKAS_41971024_POL
Smithsonian breeds endangered species
July 24, 2014 - Front Royal, Virginia, United States: Dolores Reed, a supervisory biologist, gets a nuzzle from a Przewalski horse at the Smithsonian Conservation Biology Institute. The horses were considered extinct in the wild until 2008, when the World Conservation Union reclassified them as critically endangered. Scientists at the Zoo are working to increase the genetic diversity of Przewalski's horses. (Evelyn Hockstein/Polaris) (FOTO:DUKAS/POLARIS)
DUKAS/POLARIS -
DUKAS_41971022_POL
Smithsonian breeds endangered species
July 24, 2014 - Front Royal, Virginia, United States: Przewalski's horses leave the barn after eating to head to the pasture at the Smithsonian Conservation Biology Institute. The horses were considered extinct in the wild until 2008, when the World Conservation Union reclassified them as critically endangered. Scientists at the Zoo are working to increase the genetic diversity of Przewalski's horses. (Evelyn Hockstein/Polaris) (FOTO:DUKAS/POLARIS)
DUKAS/POLARIS -
DUKAS_41971021_POL
Smithsonian breeds endangered species
July 24, 2014 - Front Royal, Virginia, United States: Dama gazelles are bred at the Smithsonian Conservation Biology Institute. The World Conservation Union's Red List of Threatened Species lists the dama gazelle as critically endangered. There may be only a few hundred of these gazelles left in the wild. (Evelyn Hockstein/Polaris) (FOTO:DUKAS/POLARIS)
DUKAS/POLARIS -
DUKAS_41971019_POL
Smithsonian breeds endangered species
July 24, 2014 - Front Royal, Virginia, United States: Dolores Reed, a supervisory biologist, gets a nuzzle from a Przewalski horse at the Smithsonian Conservation Biology Institute. The horses were considered extinct in the wild until 2008, when the World Conservation Union reclassified them as critically endangered. Scientists at the Zoo are working to increase the genetic diversity of Przewalski's horses. (Evelyn Hockstein/Polaris) (FOTO:DUKAS/POLARIS)
DUKAS/POLARIS -
DUKAS_41971017_POL
Smithsonian breeds endangered species
July 24, 2014 - Front Royal, Virginia, United States: Przewalski's horses feed at the Smithsonian Conservation Biology Institute. The horses were considered extinct in the wild until 2008, when the World Conservation Union reclassified them as critically endangered. Scientists at the Zoo are working to increase the genetic diversity of Przewalski's horses. (Evelyn Hockstein/Polaris) (FOTO:DUKAS/POLARIS)
DUKAS/POLARIS -
